Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on June 13, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
More...
